Q2 2024 · 13F-HR
Commodore Capital LPholdings as filed
Filed 2024-08-14 · accession 0001880562-24-000002
$1.47B
Reported value
35
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N5749R100 | 2GH | MERUS N V | $189.3M | 12.9% | 3,200,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $112.9M | 7.70% | 1,487,756 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $107.4M | 7.33% | 2,754,266 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $98.5M | 6.73% | 1,305,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $92.9M | 6.34% | 3,973,245 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $89.5M | 6.11% | 2,475,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $82.1M | 5.60% | 9,738,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $58.1M | 3.97% | 1,425,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $52.7M | 3.60% | 1,425,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $51.5M | 3.52% | 7,145,888 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $50.3M | 3.43% | 1,225,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $50.2M | 3.42% | 1,884,361 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $46.7M | 3.19% | 1,988,084 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $46.4M | 3.17% | 4,657,345 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $34.0M | 2.32% | 1,810,175 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $33.1M | 2.26% | 1,375,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $32.9M | 2.25% | 2,528,032 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $32.8M | 2.24% | 1,593,350 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $24.5M | 1.67% | 4,151,034 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $24.0M | 1.64% | 1,464,105 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $20.1M | 1.37% | 1,545,426 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $19.8M | 1.35% | 750,990 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $17.0M | 1.16% | 1,284,110 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $16.9M | 1.16% | 825,000 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $15.8M | 1.08% | 3,410,384 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $14.1M | 0.97% | 2,000,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $11.4M | 0.78% | 290,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $8.2M | 0.56% | 1,100,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.5M | 0.52% | 750,000 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $7.3M | 0.50% | 200,000 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $5.5M | 0.37% | 1,575,000 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.1M | 0.35% | 500,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $4.1M | 0.28% | 1,178,723 | Common | SOLE |
| 00211Y506 | ABIOEUR | ARCA BIOPHARMA INC | $1.6M | 0.11% | 414,325 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $498,800 | 0.03% | 40,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.